Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study
Chari, Ajai, Rodriguez‐Otero, Paula, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania, Sureda Balari, Anna, Perrot, Aurore, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladimir, Karlin, Lionel, Pour, Ludek, Parasrampuria, Dolly A., Masterson, Tara, Kosh, Michele, Yang, Shiyi, Delioukina, Maria, Qi, Ming, Carson, Robin, Touzeau, Cyrille
Published in British journal of haematology (01.03.2021)
Published in British journal of haematology (01.03.2021)
Get full text
Journal Article
Real‐world study on adoption of standard‐of‐care for transplant‐eligible newly diagnosed multiple myeloma patients between 2017 and 2020/2021 across France, Germany, Spain, and Italy
Weisel, Katja, Wadlund, Astrid Ottosson, Gungor, Guntug, Dergarabetian, Eileen, Pacheco, Cécile, Masurkar, Nihar, Rodriguez‐Otero, Paula
Published in European journal of haematology (01.10.2022)
Published in European journal of haematology (01.10.2022)
Get full text
Journal Article
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group
Ocio, Enrique M., Motlló, Cristina, Rodríguez‐Otero, Paula, Martínez‐López, Joaquín, Cejalvo, Mª José, Martín‐Sánchez, Jesús, Bladé, Joan, García‐Malo, Mª Dolores, Dourdil, Mª Victoria, García‐Mateo, Aránzazu, Arriba, Felipe, García‐Sanz, Ramón, Rubia, Javier, Oriol, Albert, Lahuerta, Juan‐José, San‐Miguel, Jesús F., Mateos, María‐Victoria
Published in British journal of haematology (01.02.2021)
Published in British journal of haematology (01.02.2021)
Get full text
Journal Article
Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
Larocca, Alessandra, Leleu, Xavier, Touzeau, Cyrille, Bladé, Joan, Paner, Agne, Mateos, María‐Victoria, Cavo, Michele, Maisel, Christopher, Alegre, Adrían, Oriol, Albert, Raptis, Anastasios, Rodriguez‐Otero, Paula, Mazumder, Amitabha, Laubach, Jacob, Nadeem, Omar, Sandberg, Anna, Orre, Marie, Torrång, Anna, Bakker, Nicolaas A., Richardson, Paul G.
Published in British journal of haematology (01.02.2022)
Published in British journal of haematology (01.02.2022)
Get full text
Journal Article
Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia
AGIRRE, Xabier, VILAS-ZORNOZA, Amaia, RIFON, José, BANDRES, Eva, CALASANZ, Maria José, MARTIN, Vanesa, HEINIGER, Anabel, TORRES, Antonio, SIEBERT, Reiner, ROMAN-GOMEZ, José, PROSPER, Felipe, JIMENEZ-VELASCO, Antonio, IGNACIO MARTIN-SUBERO, José, CORDEU, Lucia, GARATE, Leire, SAN JOSE-ENERIZ, Edurne, ABIZANDA, Gloria, RODRIGUEZ-OTERO, Paula, FORTES, Puri
Published in Cancer research (Chicago, Ill.) (15.05.2009)
Published in Cancer research (Chicago, Ill.) (15.05.2009)
Get full text
Journal Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
Richardson, Paul G., Schjesvold, Fredrik, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, Rodriguez‐Otero, Paula, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Beksac, Meral, Oriol, Albert, Lindsay, Jindriska, Liberati, Anna Marina, Galli, Monica, Robak, Pawel, Larocca, Alessandra, Yagci, Munci, Vural, Filiz, Kanate, Abraham S., Jiang, Ruiyun, Grote, Lara, Peluso, Teresa, Dimopoulos, Meletios
Published in European journal of haematology (01.01.2022)
Published in European journal of haematology (01.01.2022)
Get full text
Journal Article
Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts
Amundarain, Ane, Valcárcel, Luis V., Ordoñez, Raquel, Garate, Leire, Miranda, Estíbaliz, Cendoya, Xabier, Carrasco‐Leon, Arantxa, Calasanz, María José, Paiva, Bruno, Meydan, Cem, Mason, Christopher E., Melnick, Ari, Rodriguez‐Otero, Paula, Martín‐Subero, José I., San Miguel, Jesús, Planes, Francisco J., Prósper, Felipe, Agirre, Xabier
Published in American journal of hematology (01.03.2022)
Published in American journal of hematology (01.03.2022)
Get full text
Journal Article
Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study
Tomasson, Michael H., Iida, Shinsuke, Niesvizky, Ruben, Mohty, Mohamad, Bahlis, Nizar J., Martinez‐Lopez, Joaquin, Koehne, Guenther, Rodriguez‐Otero, Paula, Miles Prince, H., Viqueira, Andrea, Leip, Eric, Conte, Umberto, Sullivan, Sharon T., Lesokhin, Alexander M.
Published in HemaSphere (01.07.2024)
Published in HemaSphere (01.07.2024)
Get full text
Journal Article
Epigenetic regulation of the non‐canonical Wnt pathway in acute myeloid leukemia
Martín, Vanesa, Valencia, Ana, Agirre, Xabier, Cervera, Jose, Jose‐Eneriz, Edurne San, Vilas‐Zornoza, Amaia, Rodriguez‐Otero, Paula, Sanz, Miguel A., Herrera, Concepción, Torres, Antonio, Prosper, Felipe, Román‐Gómez, Jose
Published in Cancer science (01.02.2010)
Published in Cancer science (01.02.2010)
Get full text
Journal Article
Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant‐ineligible Multiple Myeloma Patients
Ocio, Enrique M., Bringhen, Sara, Martinez‐Lopez, Joaquin, San‐Miguel, Jesus, Oliva, Stefania, Rodriguez‐Otero, Paula, Le Roux, Nadia, Dong, Yvonne, Doroumian, Severine, Macé, Sandrine, Mateos, Maria‐Victoria
Published in HemaSphere (01.02.2023)
Published in HemaSphere (01.02.2023)
Get full text
Journal Article
P883: ALNUCTAMAB (ALNUC; BMS‐986349; CC‐93269), A BCMA × CD3 T‐CELL ENGAGER, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): LATEST RESULTS FROM A PHASE 1 FIRST‐IN‐HUMAN CLINICAL STUDY
Wong, Sandy W., Bar, Noffar, Victoria Mateos, María, Ribas, Paz, Hansson, Markus, Paris, Laura, Hofmeister, Craig, Rodriguez‐Otero, Paula, Aranzazu Bermúdez, Maria, Santoro, Armando, Yee, Andrew J., Creignou, Maria, Encinas, Cristina, Cerchione, Claudio, Rubia, Javier, Oriol, Albert, Ferstl, Barbara, Besemer, Britta, Chen, Jinjie, Chung, Alexander, Boss, Isaac W., Gaudy, Allison, LI, Shaoyi, Hsu, Kevin, Godwin, Colin, Burgess, Michael R., San‐Miguel, Jesús, Jose Costa, Luciano
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma
Alegre, Adrián, Rubia, Javier, Sureda Balari, Anna, Encinas Rodríguez, Cristina, Suárez, Alexia, Blanchard, María Jesús, Bargay Lleonart, Joan, Rodríguez‐Otero, Paula, Insunza, Andrés, Palomera, Luis, Peñarrubia, María Jesús, Ríos‐Tamayo, Rafael, Casado Montero, Luis Felipe, González, Marta Sonia, Potamianou, Anna, Couturier, Catherine, Pei, Huiling, Hevia, Henar, Milionis, Iordanis, Gaudig, Maren, Mateos, María‐Victoria
Published in HemaSphere (01.06.2020)
Published in HemaSphere (01.06.2020)
Get full text
Journal Article
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Lonial, Sagar, Lee, Hans C, Badros, Ashraf, Trudel, Suzanne, Nooka, Ajay K, Chari, Ajai, Abdallah, Al-Ola, Callander, Natalie, Lendvai, Nikoletta, Sborov, Douglas, Suvannasankha, Attaya, Weisel, Katja, Karlin, Lionel, Libby, Edward, Arnulf, Bertrand, Facon, Thierry, Hulin, Cyrille, Kortüm, K Martin, Rodríguez-Otero, Paula, Usmani, Saad Z, Hari, Parameswaran, Baz, Rachid, Quach, Hang, Moreau, Philippe, Voorhees, Peter M, Gupta, Ira, Hoos, Axel, Zhi, Eric, Baron, January, Piontek, Trisha, Lewis, Eric, Jewell, Roxanne C, Dettman, Elisha J, Popat, Rakesh, Esposti, Simona Degli, Opalinska, Joanna, Richardson, Paul, Cohen, Adam D
Published in The lancet oncology (01.02.2020)
Published in The lancet oncology (01.02.2020)
Get full text
Journal Article
The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Moreno, Laura, Perez, Cristina, Zabaleta, Aintzane, Manrique, Irene, Alignani, Diego, Ajona, Daniel, Blanco, Laura, Lasa, Marta, Maiso, Patricia, Rodriguez, Idoia, Garate, Sonia, Jelinek, Tomas, Segura, Victor, Moreno, Cristina, Merino, Juana, Rodriguez-Otero, Paula, Panizo, Carlos, Prosper, Felipe, San-Miguel, Jesus F, Paiva, Bruno
Published in Clinical cancer research (15.05.2019)
Published in Clinical cancer research (15.05.2019)
Get full text
Journal Article
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Ludwig, Heinz, Terpos, Evangelos, van de Donk, Niels, Mateos, Maria-Victoria, Moreau, Philippe, Dimopoulos, Melitios-Athanasios, Delforge, Michel, Rodriguez-Otero, Paula, San-Miguel, Jesús, Yong, Kwee, Gay, Francesca, Einsele, Hermann, Mina, Roberto, Caers, Jo, Driessen, Christoph, Musto, Pellegrino, Zweegman, Sonja, Engelhardt, Monika, Cook, Gordon, Weisel, Katja, Broijl, Annemiek, Beksac, Meral, Bila, Jelena, Schjesvold, Fredrik, Cavo, Michele, Hajek, Roman, Touzeau, Cyrille, Boccadoro, Mario, Sonneveld, Pieter
Published in The lancet oncology (01.06.2023)
Published in The lancet oncology (01.06.2023)
Get full text
Journal Article
Web Resource
Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study
Mateos, Maria‐Victoria, Orlowski, Robert Z., Ocio, Enrique M., Rodríguez‐Otero, Paula, Reece, Donna, Moreau, Philippe, Munshi, Nikhil, Avigan, David E., Siegel, David S., Ghori, Razi, Farooqui, Mohammed Z. H., Marinello, Patricia, San-Miguel, Jesus
Published in British journal of haematology (01.09.2019)
Published in British journal of haematology (01.09.2019)
Get full text
Journal Article
A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies
Zabaleta, Aintzane, Blanco, Laura, Kim, Peter S, Bisht, Kamlesh, Wang, Hongfang, Van de Velde, Helgi, Lasa, Marta, Tamariz-Amador, Luis-Esteban, Rodriguez-Otero, Paula, San-Miguel, Jesús, Paiva, Bruno, Martín-Sánchez, Esperanza
Published in British journal of haematology (22.09.2024)
Published in British journal of haematology (22.09.2024)
Get full text
Journal Article